Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia

      This paper is only available as a PDF. To read, Please Download here.


      The effect of combined hydrochlorothiazide and furosemide therapy was studied in eight hypertensive patients with renal insufficiency who had a poor response to either furosemide or hydrochlorothiazide alone. The study was divided into two parts. In part A, five patients who had an inadequate response to furosemide in doses of 160 to 240 mg/day followed a strict protocol in order to compare the effect of increased doses of furosemide with combined hydrochlorothiazide-furosemide administration. All had azotemia, presumably from nephrosclerosis, and had serum creatinine concentrations ranging from 2.3 to 4.9 mg/dl. Four of the five patients had inadequate arterial pressure control, and the remaining patient had fluid retention from the administration of minoxidil. In all five patients, plasma volume was either increased or normal, despite long-term treatment with furosemide. Increasing the dose of furosemide to between 320 and 480 mg/day had only a modest additional diuretic effect, and plasma volume and arterial pressure were not significantly changed. Adding hydrochlorothiazide, 25 to 50 mg twice a day, produced a marked diuresis, and a significant reduction in weight, plasma volume and mean arterial pressure (p < 0.025 for all three patients). In part B, combined hydrochlorothiazide-furosemide therapy was used to treat three additional patients who had an inadequate response to either diuretic alone. The results indicate that combined hydrochlorothiazide-furosemide is a potent diuretic regimen and is effective in many patients with chronic renal failure who have a poor response to furosemide alone.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Reubi FC
        Clinical use of furosemide.
        Ann NY Acad Sci. 1966; 139: 433
        • Reubi FC
        • Cottier PT
        Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics.
        Circulation. 1961; 23: 200
        • Gregory Jr, LF
        • Durrett RR
        • Robinson RR
        • Clapp JR
        The short-term effect of furosemide on electrolyte and water excretion in patients with severe renal disease.
        Arch Intern Med. 1970; 125: 69
        • Reineck HJ
        • Stein JH
        Mechanisms of action and clinical uses of diuretics.
        in: Brenner BM Rector Jr, FC The kidney. 2nd ed. W B Saunders, Philadelphia1981: 1097
        • Jacobson HR
        • Kokko JP
        Diuretics sites and mechanisms of action.
        Annu Rev Pharmacol Toxicol. 1976; 16: 201
        • Goldberg M
        The renal physiology of diuretics.
        in: 2nd ed. Handbook of physiology. American Physiological Society, Washington, DC1973: 1003
        • Clapp JR
        • Robinson RR
        Distal sites of action of diuretic drugs in the dog nephron.
        Am J Physiol. 1968; 215: 228
        • Earley LE
        • Friedler RM
        Renal tubular effects of ethacrynic acid.
        J Clin Invest. 1964; 43: 1495
        • Israelit AH
        • Long DL
        • White MG
        • Hull AR
        Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate.
        Kidney Int. 1973; 4: 346
        • Ott NT
        • Wilson DM
        A simple technique for estimating glomerular filtration rate with subcutaneous injection of 125I-iothalamate.
        in: 2nd ed. Mayo Clin Proc. 50. 1975: 664
        • Walker HK
        • Hall WD
        • Hurst JW
        Clinical methods: the history, physical and laboratory examinations. 2nd ed. Butterworth, Boston1980
        • Tarazi RC
        • Frohlich ED
        • Dustan HP
        Plasma volume in men with essential hypertension.
        N Engl J Med. 1968; 278: 762
        • Tarazi RC
        • Dustan HP
        • Frohlich ED
        • Gifford Jr, RW
        • Hoffman GC
        Plasma volume and chronic hypertension. Relationship to arterial pressure levels in different hypertensive diseases.
        Arch Intern Med. 1970; 125: 835
        • Chien S
        • Usami S
        • Simmons RL
        • et al.
        Blood volume and age: repeated measurements on normal men after 17 years.
        J Appl Physiol. 1966; 21: 583
        • Bravo EL
        • Tarazi RC
        • Dustan HP
        On the mechanism of suppressed plasma-renin activity during beta-adrenergic blockage with propranolol.
        J Lab Clin Med. 1974; 83: 118
        • Croxton FE
        • Cowden DJ
        Applied general statistics.
        Prentice Hall, New York1944
        • Tarazi RC
        • Dustan HP
        • Bravo EL
        The importance of plasma volume in the treatment of hypertension.
        in: Schweizer W Beta-blockers—present status and future prospects. Hans Huber Publishers, Bern, Switzerland1974: 102
        • Dustan HP
        • Tarazi RC
        • Bravo EL
        Dependence of arterial pressure on intravascular volume in treated hypertensive patients.
        N Engl J Med. 1972; 286: 861
        • Dustan HP
        • Page IH
        Some factors in renal and renoprival hypertension.
        J Lab Clin Med. 1964; 64: 948
        • Onesti G
        • Kim KE
        • Greco JA
        • et al.
        Blood pressure regulation in end-stage renal disease and anephric man.
        Circ Res. 1975; 36 & 37: 145
        • Frohlich ED
        • Tarazi RC
        • Dustan HP
        Hemodynamic and functional mechanisms in two renal hypertensions: arterial and pyelonephritis.
        Am J Med Sci. 1971; 261: 189
        • Tarazi RC
        Hemodynamic role of extracellular fluid in hypertension.
        Circ Res. 1976; 38: 73
        • Tarazi RC
        • Dustan HP
        • Frohlich ED
        Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity.
        Circulation. 1970; 41: 709
        • Bravo EL
        • Dustan HP
        • Tarazi RC
        Spironolactone as a non-specific treatment for primary aldosteronism.
        Circulation. 1973; 48: 491
        • Leth A
        • Ibsen H
        Changes in the ratio of plasma to interstitial fluid volume during long-term antihypertensive therapy.
        J Lab Clin. 1976; 87: 781
        • Wilson IM
        • Freis ED
        Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide.
        Circulation. 1959; 20: 1028
        • Dustan HP
        • Bravo EL
        • Tarazi RC
        Volume-dependent essential and steroid hypertension.
        Am J Cardiol. 1973; 31: 606
        • Dunn MJ
        • Tannen RL
        Low-renin hypertension.
        Kidney Int. 1974; 5: 317
        • Tarazi RC
        • Frohlich ED
        • Dustan HP
        Plasma volume changes with long-term beta-adrenergic blockade.
        Am Heart J. 1971; 82: 770
        • Finnerty Jr, FA
        • Davidov M
        • Mroczek WJ
        • Gavrilovich L
        Influence of extracellular fluid volume on response to antihypertensive drugs.
        Circ Res. 1970; 27: 71
        • Epstein M
        • Lepp BA
        • Hoffman DS
        • Levinson R
        Potentiation of furosemide by metolazone in refractory edema.
        Curt Ther Res. 1977; 21: 656
        • Gunstone RF
        • Wing AJ
        • Shani HGP
        • et al.
        Clinical experience with metalazone in fifty-two African patients: synergy with furosemide.
        Postgrad Med J. 1971; 47: 789
        • Olesen KH
        The natriuretic effect addition of quinethazone and furosemide in congestive heart failure.
        Acta Med Scand. 1971; 190: 229
        • Olesen KH
        • Sigurd B
        The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure.
        Acta Med Scand. 1971; 190: 233
        • Robson AO
        • Ashcroft R
        • Kerr DNS
        • Teasdale G
        The diuretic response to furosemide.
        Lancet. 1964; 2: 1085
        • Kunau Jr, RT
        • Weller DR
        • Webb HL
        Clarification of the site of action of chlorothiazide in the rat nephron.
        J Clin Invest. 1975; 56: 401
        • Fernandez PC
        • Puschett JB
        Proximal tubular actions of metolazone and chlorothiazide.
        Am J Physiol. 1973; 225: 954
        • Burg MB
        Mechanisms of action of diuretic drugs.
        in: Brenner BM Rector Jr, FC The kidney. 1st ed. WB Sanders, Philadelphia1976: 737